EDNRA and systemic sclerosis: Importantly, higher levels of anti-AT1R and anti-ETaR antibodies are associated with severe SSc complications, such as diffuse skin involvement, ILD, PAH, SRC and digital ulcers, and poor prognosis [108,111].